<DOC>
	<DOC>NCT00487656</DOC>
	<brief_summary>The purpose of this study is to see if ART-123 (recombinant human soluble thrombomodulin) decreases the number of people who die as a result of Disseminated Intravascular Coagulation (DIC) complication of sepsis.</brief_summary>
	<brief_title>Safety and Efficacy of ART-123 in Subjects With Sepsis and Disseminated Intravascular Coagulation</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Disseminated Intravascular Coagulation</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Infection or suspected infection resulting in sepsis and DIC Unable to provide informed consent, or lack of consent from an acceptable surrogate Subjects &lt; 18 years of age Known conditions that could confound the diagnosis of DIC due to sepsis Known conditions that increase the risk of bleeding Known medical condition associated with a hypercoagulable state Known or suspected severe liver disease History of solid organ (excluding uncomplicated kidney), bone marrow or stem cell transplantation Renal failure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>